Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice

Journal of Human Virology

Volumn 2, Issue 6, 1999, Pages 369-379

  Merkle, Ingrid ^a,c   Tonew, Marion ^b   Glück, Brigitte ^a   Schmidtke, Michaela ^a   Egerer, Renate ^a   Stelzner, Axel ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Coxsackievirus B3; Outbred mouse model; Semi nested polymerase chain reaction; Viral chronic myocarditis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; COXSACKIE VIRUS B3; DISEASE COURSE; HISTOPATHOLOGY; MOUSE; MYOCARDITIS; NONHUMAN; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

ANIMALS; ANTIBODIES, VIRAL; CHRONIC DISEASE; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HEART; HUMANS; MALE; MICE; MYOCARDITIS; MYOCARDIUM; PANCREAS; RNA, VIRAL; VIRUS REPLICATION;

ANIMALIA; COXSACKIEVIRUS;

EID: 0033508404     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bowles NE, Rose ML, Taylor P, et al. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989;80:1128-1137.
2. Muir P, Archard LC. There is evidence for persistent enterovirus infections in chronic medical conditions in humans. Rev Med Virol 1994;4:245-250.
3. Nicholson F, Ajetunmobi JF, Li M, et al. Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis. Br Heart J 1995;74:522-527.
4. Gauntt CJ, Pallansch MA. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res 1996;41:89-99.
5. Huber SA. Viral myocarditis: A tale of two diseases. Lab Invest 1992;66(1):1-2.
6. Herskowitz A, Neumann DA, Ansari AA. Concepts of autoimmunity applied to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993;22(5):1385-1388.
7. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994;74(2): 182-188.
8. Kandolf R, Canu A, Hofschneider PH. Coxsackie B3 virus can replicate in cultured human fetal heart cells and is inhibited by interferon. J Mol Cell Cardiol 1985;17:167-181.
9. Tonew M, Hartmann M, Schmidtke M, Stelzner A. Replication and persistence of coxsackievirus B3 in human fibroblasts. Zbl Bakt 1995;282:92-101.
10. Leparc I, Fuchs F, Kopecka H, Aymard M. Use of the polymerase chain reaction with a murine model of picornavirus-induced myocarditis. J Clin Microbiol 1993;31 (11):2890-2894.
11. Sato S, Tsutsumi R, Burke A, et al. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions. J Gen Virol 1994;75:2911-2924.
12. Rabausch-Starz I, Schwaiger A, Grünewald K, Müller-Hermelink HK, Neu N. Persistence of virus and viral genomes in myocardium after coxsackievirus B3-induced murine myocarditis. Clin Exp Immunol 1994;96:69-74.
13. Kishimoto C, Ochiai H, Sasayama S. Immunological mechanism in experimental coxsackievirus B3 myocarditis in mice. Jpn Circ J 1991;55:1144-1148.
14. McManus BM, Chow LH, Wilson JE, et al. Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993;68(2):159-169.
15. Arola A, Kalimo H, Ruuskanen O, Hyypiä T. Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods. J Med Virol 1995;47:251-259.
16. Huber SA, Lodge PA. Coxsackie virus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986;122:284-291.
17. Loria RM. Host conditions affecting the course of coxsackievirus infections. In: Bendinelli M, Friedman H, ed. Coxsackieviruses - General Update. New York: Plenum, 1988:135-157.
18. Cabinian AE, Kiel RJ, Smith F, Ho KL, Khatib R, Reyes MP. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model. J Lab Clin Med 1990;115(4):454-462.
19. Kruppenbacher JP, Arnold G, Mertens T, Fischer A, Zimmermann J, Eggers HJ. Outbred mice infected by an encephalomyocarditis virus variant: a model for studying chronic viral heart disease. Virchows Arch A Pathol Anat 1993;422:405-413.
20. Chow LH, Gauntt CJ, McManus BM. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. Lab Invest 1991;64(1):55-64.
21. Zhang H, Yousef GE, Ouyang X, Archard LC. Characterization of a murine model of myocarditis induced by reactivated coxsackievirus B3. Int J Exp Pathol 1994;75: 99-110.
22. Tonew M, Wagner B, Wagner M, Schmidtke M, Stelzner A. Permissiveness of human embryonal fibroblasts for coxsackievirus B3: investigations on virus genetic markers in vitro and localization of virus receptor distribution by immunogold replica technique. Zbl Bakt 1996;284: 443-456.
23. Reed LJ, Muench HA. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-497.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
25. Huber SA, Job LP, Auld KR. Influence of sex hormones on coxsackie B-3 virus infection in Balb/c mice. Cell Immunol 1982;67:173-189.
26. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 1987;84:6272-6276.
27. Kandolf R, Klingel K, Zell R, et al. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 1993;35:140-151.
28. Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992;89:314-318.
29. Klingel K, Kandolf R. Molecular in situ localization techniques in diagnosis and pathogenicity studies of enteroviral heart disease. Clin Diagn Virol 1996;5:157-166.
30. Andréoletti L, Hober D, Becquart P, et al. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardial infection. J Med Virol 1997;52:206-214.
31. + T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995;69:6720-6728.
32. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW. Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. JAm Coll Cardiol 1987;9;1311-1319.
33. Lodge PA, Herzum M, Olszewski J, Huber SA. Coxsackie B3 myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 1987;128:455-463.
34. Seyer JM, Hutcheson TE, Kang AH. Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest 1976;57:1498-1507.
35. Leslie KO, Schwarz J, Simpson K, Huber SA. Progressive interstitial collagen deposition in coxsackievirus B3-induced murine myocarditis. J Pathol 1990;136:683-693.
36. Adachi K, Muraishi A, Seki Y, Yamaki K, Yoshizuka M. Coxsackievirus B3 genomes detected by polymerase chain reaction: evidence of latent persistency in the myocardium in experimental murine myocarditis. Histol Histopathol 1996;11:587-596.
37. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Lab Invest 1992;86:522-530.
38. Heim A, Stille-Siegener M, Kandolf R, Kreuzer H, Figulla HR. Enterovirus-induced myocarditis: Hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-α. Clin Cardiol 1994;17: 563-565.
39. Heim A, Brehm C, Stille-Siegener M, et al. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-α is more effective than recombinant interferon-α 2a in carrier-state coxsackievirus B3 replication. J Mol Cell Cardiol 1995;27:2199-2208.
40. Huber SA, Polger J, Schultheiss P, Schwimmbeck P. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 1994;68:195-206.
41. Seyer JM, Eldrige T, Hutcheson TE, Kang AH. Collagen polymorphism in normal liver and cirrhotic liver. J Clin Invest 1977;59:241-248.